Fact CheckerSign in

NCT05946512Recruiting

MR-spectroscopy in Post-covid Condition Prior to and Following a Yoga Breathing Intervention

MR Spectroscopy in Well-characterized Individuals With and Without Post COVID Condition Prior to and Following a Yoga Breathing Intervention- an Explorative Randomised Controlled Trial

Source: ClinicalTrials.gov · Last updated 14 Jul 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

From a clinical perspective, we find that many patients with Post COVID condition suffer from severe and debilitating shortness of breath, while routine pulmonary investigations fail to find the cause of the problems experienced. If dyspnea is associated with palpitations, dizziness or anxiety, patients are commonly diagnosed with "dysfunctional breathing". From a psychosomatic perspective, the symptom of dysfunctional breathing can be classified as a "functional symptom" under the umbrella term of somatic symptom disorder. Therefore, Yoga interventions with special emphasis on breath-guided relaxation are a promising approach. We aim to investigate the psycho-somatic and somato-psychic pathophysiology on a morphological, psychological, functional and biological basis underlying the symptom of dysfunctional breathing. Furthermore, we plan to investigate the mechanism of Yoga intervention on the mental and somatic symptom burden of participants with Post COVID condition. Then, we aim to compare the impact of Yoga on other groups - healthy individuals, patients with chronic obstructive lung disease (COPD), as well as those with somatic symptom disorder. As a control intervention to Yoga guided breathing exercises a social contact group will be used.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
320 (estimated)
First submitted
13 Jul 2023
Start date
24 Jul 2023
Primary completion date
24 Jul 2026
Lead sponsor
Medical University Innsbruck
NCT number
NCT05946512

What you commit to

  • Study type: Interventional
  • Planned participants: 320
  • From 24 Jul 2023 to the primary completion date, 24 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Exclusion criteria for participants with post COVID condition
    • Conditions precluding magnetic resonance imaging (MRI) such as metal implants in the body (e.g., pacemakers, surgical devices), phobic anxiety, claustrophobia, or pregnancy.
    • Active psychiatric conditions interfering with study participation such as psychosis or acute suicidality.
    • Severe fatigue interfering with study participation.
    • Previous evidence of structural brain abnormality on the structural MRI scan.
    • Significant previous meditation or Yoga experience.
    • Patients with known carotid stenosis \>70% or cardiopulmonary contraindications for tilt table and other cardiovascular autonomic function tests (e.g. Valsalva maneuver, deep breathing, standing test).
  • Previous evidence of structural brain abnormality on the structural MRI scan.
  • Significant previous meditation or Yoga experience.
  • Patients dependent on a long-term oxygen therapy (LTOT )
  • Previous evidence of structural brain abnormality on the structural MRI scan.
  • Significant previous meditation or Yoga experience.
  • Previous evidence of structural brain abnormality on the structural MRI scan.
  • Significant previous meditation or Yoga experience.

Other illness

  • Conditions precluding magnetic resonance imaging (MRI) such as metal implants in the body (e.g., pacemakers, surgical devices), phobic anxiety, claustrophobia, or pregnancy.
  • Active psychiatric conditions interfering with study participation such as psychosis or acute suicidality.
  • Medical history of post COVID condition.
  • Conditions precluding magnetic resonance imaging (MRI) such as metal implants in the body (e.g., pacemakers, surgical devices), phobic anxiety, claustrophobia, or pregnancy.
  • Other active psychiatric conditions interfering with study participation such as psychosis or acute suicidality.
  • Medical history of post COVID condition.
  • Conditions precluding magnetic resonance imaging (MRI) such as metal implants in the body (e.g., pacemakers, surgical devices), phobic anxiety, claustrophobia, or pregnancy.
  • Active psychiatric conditions interfering with study participation such as psychosis or acute suicidality.
  • Medical history of post COVID condition.
  • Patients with known carotid stenosis \>70% or cardiopulmonary contraindications for tilt table and other cardiovascular autonomic function tests (e.g. Valsalva maneuver, deep breathing, standing test).
    • legend: PRECISE = a study conducted with participants with post-COVID-19 condition at the Medical University of Innsbruck; mMRC score = modified medical research council score; DB = dysfunctional breathing; MIP = maximal inspiratory pressure; COPD = chronic obstructive pulmonary disease; FEV1/FVC = forced expiratory volume in one second/ forced vital capacity; SSD-12 = Somatic Symptom Disorder - B Criteria Scale; SSS-8 = Somatic Symptom Scale - 8;

Other

  • Severe fatigue interfering with study participation.
  • Patients with known carotid stenosis \>70% or cardiopulmonary contraindications for tilt table and other cardiovascular autonomic function tests (e.g. Valsalva maneuver, deep breathing, standing test).
  • Severe fatigue interfering with study participation.
  • Patients with known carotid stenosis \>70% or cardiopulmonary contraindications for tilt table and other cardiovascular autonomic function tests (e.g. Valsalva maneuver, deep breathing, standing test).

Who the study is looking for

  • Inclusion criteria for participants with Post COVID condition
    • Eligible patients will be recruited at the Respiratory Outpatient Clinic (Medical University Innsbruck, Internal Medicine II) from the PRECISE registry or from other participating clinics at Medical University Innsbruck and via local advertisement.
    • Persistent respiratory symptoms for 3 months after infection (mMRC dyspnea score ≥ 1).
    • Absence of obstructive or restrictive lung disease or unilateral diaphragmatic paresis.
    • Medical history with symptoms compatible with DB as assessed by the physician AND Nijmegen cut-off score of \>23 or reduced MIP. The last two conditions were chosen to provide a readily accessible and objectifiable entry criterion at the inclusion visit.
    • Age \>= 18 years, \< 50 years.
    • Sufficient knowledge of German language for interaction during Yoga and completion of questionnaires.
  • Eligible patients will be recruited at the Respiratory Outpatient Clinic (Medical University Innsbruck).
  • A postbronchodilator FEV1/FVC ratio less than 0,7 obtained in functional pulmonary testing is required fo diagnosis of COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) Science Committee, 2022).
  • Persistent respiratory symptoms for 3 months (mMRC≥ 1).
  • Absence of unilateral diaphragmatic paresis.
  • Medical history with symptoms compatible with DB as assessed by the physician AND Nijmegen cut-off score of \>23 or reduced MIP. The last two conditions were chosen to provide a readily accessible and objectifiable entry criterion at the inclusion visit.
  • Age \>= 18 years, \< 50 years
  • Sufficient knowledge of German language for interaction during Yoga and completion of questionnaires
  • Eligible patients will be recruited at University Hospital for Psychiatry I and II, Medical University Innsbruck) and via local advertisement.
  • Screening positive for somatic symptoms disorder with the following scores: SSD-12 ≥ 23, SSS-8 ≥ 9.
  • Persistent respiratory symptoms for 3 months after infection (mMRC≥ 1).
  • Absence of obstructive or restrictive lung disease or unilateral diaphragmatic paresis.
  • Absence of medical history with symptoms compatible with DB as assessed by the physician AND Nijmegen cut-off score of \>23 or reduced MIP. The last two conditions were chosen to provide a readily accessible and objectifiable entry criterion at the inclusion visit.
  • Age \>= 18 years, \< 50 years.
  • Sufficient knowledge of German language for interaction during Yoga and completion of questionnaires.
  • Eligible participants will be recruited via local advertisement.
  • Absence of significant active mental or somatic disorders
  • Absence of persistent respiratory symptoms (mMRC\< 1).
  • Absence of obstructive or restrictive lung disease or unilateral diaphragmatic paresis.
  • Absence of medical history with symptoms compatible with DB as assessed by the physician AND Nijmegen questionnaire and MIP within normal limits..
  • Age \>= 18 years, \< 50 years.
  • Sufficient knowledge of German language for interaction during Yoga and completion of questionnaires.

Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medizinische Universität Innsbruck
Coordinator of this site? Confirm its status
InnsbruckAustriaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.